Prostacyclin Formation by Rat Endothelial Layer

Thromb Haemost 1980; 43(03): 229
DOI: 10.1055/s-0038-1650061

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

H Sinzinger

¹⁾Atherosclerosis Research Group at the Department of Medical Physiology, Vienna, Austria

²⁾2nd Department of Internal Medicine, Vienna, Austria

³⁾Atherosclerosis and Thrombosis Research Commission of the Austrian Academy of Sciences, Vienna, Austria
K Silberbauer

²⁾2nd Department of Internal Medicine, Vienna, Austria

³⁾Atherosclerosis and Thrombosis Research Commission of the Austrian Academy of Sciences, Vienna, Austria
W Auerswald

¹⁾Atherosclerosis Research Group at the Department of Medical Physiology, Vienna, Austria

³⁾Atherosclerosis and Thrombosis Research Commission of the Austrian Academy of Sciences, Vienna, Austria

References
1 Ts'ao CH, Holly CM, Serieno MA, Galluzzo TS. Generation of a PGI₂-like activity by deendothelialized rat aorta. Thromb Haemostas 1979; 42: 873-884
2 Sinzinger H, Silberbauer K, Auerswald W. Prostacyclin formation by human and experimental animal endothelial and smooth muscle cells. Folia Angiol 1980 28: (in press)
3 Hornstra C, Haddeman E, Don JA. Some investigations into the role of prostacyclin in thromboregulation. Thromb Res 1978; 12: 367-374
4 Sinzinger H, Silberbauer K, Auerswald W. Prostacyclin production by vascular smooth muscle and endothelial cells. Atherosclerosis V 1980; 138-141
5 Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI₂) by layers of the arterial wall. An explanation for the antithrombotic properties of the vascular endothelium. Thromb Res 1977; 11: 323-344
6 Sinzinger H, Clopath P, Silberbauer K, Winter M. Is the susceptibility of various species to atherosclerosis due to an inborn different prostacyclin (PGI₂)-formation?. Experientia 1980; 36: 321-323